Cross-Sector entity
Aeva Technologies is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Coverage clusters in earnings, which accounts for 1 of those 2, with the remainder spread across 1 other category. The tracked stories average 11 original sources each.
2 verified stories tracked
Last mentioned: Feb 27, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Aeva Technologies is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Coverage clusters in earnings, which accounts for 1 of those 2, with the remainder spread across 1 other category. The tracked stories average 11 original sources each. R. Scott Struthers appears in 2 tracked Cross-Sector stories from February 27, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering R. Scott Struthers. Shared-story counts are live from our verified record — not editorial picks.
EU Regulatory Milestone
Crinetics receives positive CHMP opinion for Palsonify in the European Union.
Crinetics Capital Raise
Public offering brings Crinetics' total liquidity to approximately $1.4B.
NVIDIA Reference Status
Aeva 4D LiDAR selected as reference sensor for NVIDIA DRIVE Hyperion.
Palsonify Launch
Crinetics initiates U.S. commercial launch of Palsonify for acromegaly.
The Q4 2025 earnings cycle highlights a significant shift toward recurring revenue and high-performance computing (HPC) across the hardware and biotech sectors. Arlo Technologies achieved a landmark Rule of 40 score, while TeraWulf and Aeva Technologies signaled deeper integrations into the AI infrastructure ecosystem.
A wave of Q4 2025 earnings reports highlights a pivotal shift for growth-stage technology and biotech firms as they transition from R&D to commercial scaling. Crinetics and Aeva Technologies emerged as standout performers, securing massive cash reserves and tier-one partnerships that validate their long-term market positions.
